JPWO2023006923A5 - - Google Patents
Info
- Publication number
- JPWO2023006923A5 JPWO2023006923A5 JP2024504971A JP2024504971A JPWO2023006923A5 JP WO2023006923 A5 JPWO2023006923 A5 JP WO2023006923A5 JP 2024504971 A JP2024504971 A JP 2024504971A JP 2024504971 A JP2024504971 A JP 2024504971A JP WO2023006923 A5 JPWO2023006923 A5 JP WO2023006923A5
- Authority
- JP
- Japan
- Prior art keywords
- agonist
- pharmaceutical composition
- hours
- compound
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21188741.9 | 2021-07-30 | ||
| EP21188741 | 2021-07-30 | ||
| PCT/EP2022/071281 WO2023006923A1 (en) | 2021-07-30 | 2022-07-28 | Dose regimen for long-acting glp1/glucagon receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024529452A JP2024529452A (ja) | 2024-08-06 |
| JP2024529452A5 JP2024529452A5 (https=) | 2025-07-30 |
| JPWO2023006923A5 true JPWO2023006923A5 (https=) | 2025-07-30 |
Family
ID=77155646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504971A Pending JP2024529452A (ja) | 2021-07-30 | 2022-07-28 | 長時間作用型ｇｌｐ１／グルカゴン受容体アゴニストのための投薬レジメン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250262279A1 (https=) |
| EP (1) | EP4376871A1 (https=) |
| JP (1) | JP2024529452A (https=) |
| KR (1) | KR20240043778A (https=) |
| CN (1) | CN117677395A (https=) |
| AU (1) | AU2022320922A1 (https=) |
| CA (1) | CA3226846A1 (https=) |
| CL (1) | CL2024000222A1 (https=) |
| MX (1) | MX2024001276A (https=) |
| WO (1) | WO2023006923A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024165571A2 (en) | 2023-02-06 | 2024-08-15 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| WO2025125576A2 (en) | 2023-12-15 | 2025-06-19 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| WO2025133348A1 (en) | 2023-12-22 | 2025-06-26 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| EP4686757A1 (en) | 2024-07-31 | 2026-02-04 | e-therapeutics PLC | Inhibitors of expression and/or function |
| WO2025196502A1 (en) | 2024-03-20 | 2025-09-25 | North Carolina Agricultural & Technical State University | Choline kinase inhibitors as a therapeutic treatment for obesity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| TWI617574B (zh) | 2012-12-11 | 2018-03-11 | 梅迪繆思有限公司 | 用於治療肥胖之升糖素與ｇｌｐ－１共促效劑 |
| US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
| WO2015055801A1 (en) | 2013-10-17 | 2015-04-23 | Zealand Pharma A/S | Acylated glucagon analogues |
| US10336802B2 (en) * | 2015-04-16 | 2019-07-02 | Zealand Pharma A/S | Acylated glucagon analogue |
| AR107890A1 (es) | 2016-03-10 | 2018-06-28 | Medimmune Ltd | Co-agonistas de glucagón y de glp-1 para el tratamiento de la obesidad |
| AR110299A1 (es) | 2016-12-02 | 2019-03-13 | Sanofi Sa | Conjugados que comprenden un agonista dual de glp-1 / glucagón, un conector y ácido hialurónico |
| AU2018314773A1 (en) * | 2017-08-09 | 2020-03-26 | Sanofi | GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis |
| WO2019060660A1 (en) * | 2017-09-25 | 2019-03-28 | Merck Sharp & Dohme Corp. | CO-AGONISTS WITH EXTENDED ACTION OF GLUCAGON AND GLP-1 RECEPTORS |
-
2022
- 2022-07-28 WO PCT/EP2022/071281 patent/WO2023006923A1/en not_active Ceased
- 2022-07-28 KR KR1020247006953A patent/KR20240043778A/ko active Pending
- 2022-07-28 US US18/291,966 patent/US20250262279A1/en active Pending
- 2022-07-28 CA CA3226846A patent/CA3226846A1/en active Pending
- 2022-07-28 MX MX2024001276A patent/MX2024001276A/es unknown
- 2022-07-28 AU AU2022320922A patent/AU2022320922A1/en active Pending
- 2022-07-28 EP EP22757584.2A patent/EP4376871A1/en active Pending
- 2022-07-28 CN CN202280051207.4A patent/CN117677395A/zh active Pending
- 2022-07-28 JP JP2024504971A patent/JP2024529452A/ja active Pending
-
2024
- 2024-01-25 CL CL2024000222A patent/CL2024000222A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2485135C2 (ru) | Соединения оксинтомодулина (варианты), фармацевтическая композиция на их основе, способы лечения и профилактики ожирения и сопутствующих заболеваний (варианты) и лекарственное средство (варианты) | |
| CN102292346B (zh) | 肥胖的治疗 | |
| JP2020002172A5 (https=) | ||
| JP2014526254A5 (https=) | ||
| CA2271169A1 (en) | Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity | |
| WO2023280152A1 (en) | Combination therapy for treatment of liver diseases | |
| JPWO2023006923A5 (https=) | ||
| JP2005506345A5 (https=) | ||
| JP2022062153A5 (https=) | ||
| WO1998031386A1 (en) | Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method | |
| JPWO2021168403A5 (https=) | ||
| CA2620065A1 (en) | Methods and formulations for modulating lyn kinase activity and treating related disorders | |
| JPWO2021123902A5 (https=) | ||
| JP2019501925A5 (https=) | ||
| CN102711797A (zh) | 治疗主动脉纤维化的组合物及方法 | |
| Opitz et al. | Systemic sclerosis–A systematic overview | |
| JP2020510011A5 (https=) | ||
| WO2024254352A9 (en) | Sglt1 inhibitor and incretin combinations for treating metabolic disease | |
| EP2521561A2 (en) | Linaclotide for the treatment of chronic constipation | |
| CN118766935A (zh) | 治疗、预防、抑制或减少细胞因子释放的噁噻嗪二氧化物 | |
| WO2023280150A1 (en) | Combination therapy for treatment of liver diseases | |
| JPWO2022053990A5 (https=) | ||
| WO2024026410A3 (en) | Neurotrophic receptor tyrosine kinase (ntrk) inhibitors and methods using same | |
| JPWO2022197901A5 (https=) | ||
| JPWO2022235663A5 (https=) |